GLP-1 weight loss drugs containing the active ingredient semaglutide were originally intended to manage Type 2 Diabetes
That same poll showed that 73% of Americans agree that providing coverage of obesity medications could improve productivity
Semaglutide GLP-1 lowers the chance of developing heart disease and some types of cancer, as well as other chronic diseases linked to obesity
You develop severe or persistent gastrointestinal symptoms after starting Mounjaro, including ongoing nausea, vomiting, diarrhoea, or abdominal pain
The drugs are changing drinking behavior through both brain and body effects
This immediate fluid replenishment combats dehydration, helps flush out alcohol toxins, and restores vital electrolyte balance